KORU Medical Systems, Inc. KRMD 深 沪
等待开盘 04-01 09:30:00 美东时间
4.32
+0.070
+1.65%
华盛通- 最 高4.43
- 今 开4.34
- 成交量 13.11万股
- 最 低 4.245
- 昨 收 4.25
- 总市值 2.00亿
- 52周最高 6.608
- 市盈率 静 --
- 换手率 0.28%
- 52周最低 2.08
- 委 比 -76.93%
- 总股本 4637.04万
- 历史最高 12.84
- 量 比 1.53
- 振 幅 4.35%
- 历史最低 1.82
- 每 手 1
- 风险率 1.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多电话会总结 ｜ KORU Medical(KRMD)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据KORU Medical业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 第四季度营收1,090万美元，同比增长23%，连续第三个季度实现超过20%的营收增长 - 全年营收4,110万美元，同比增长22%（2024年为3,360万美元） **分业务营收：** - 国内核心业务：第四季度同比增长18%，全年增长11% - 国际核心业务：第四季度同比增长71%，全年增长80%（剔除分销商调整影响后，潜在增长率为73%） - PST业务：第四季度同比下降30% **利润率表现：** - 毛利率：全年62.3%，较上年同
03-18 12:25
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
KORU Medical Systems' Freedom60 Infusion Pump Achieves Certification Under European Union Medical Devices Regulation
KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
03-13 20:02
KORU Medical Systems Appoints Adam Kalbermatten President, CEO, Succeeding Linda Tharby
KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
03-13 04:25
KORU Medical Systems Sees FY2026 Sales $47.500M-$50.000M vs $48.476M Est
KORU Medical Systems (NASDAQ:KRMD) sees FY2026 sales of $47.500 million-$50.000 million vs $48.476 million analyst estimate.
03-13 04:08
KORU Medical Systems Q4 Adj. EPS $0.01 Beats $(0.02) Estimate, Sales $10.895M Beat $10.821M Estimate
KORU Medical Systems (NASDAQ:KRMD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.02) by 150 percent. This is a 150 percent increase over losses of $(0.02) per share from
03-13 04:08
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
KORU Medical Systems shares are trading higher after the company announced FDA clearance for use of the KORU Medical FreedomEDGE infusion system to deliver RYSTIGGO.
KORU Medical Systems shares are trading higher after the company announced FDA ...
01-30 05:12
美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
2025-12-23 12:32
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
